Preferred Type of Investment:
Convertible notes
Market Problem:
One of the most critical tasks of our time is the restoration and maintenance of human microbiome health, which is the foundation of immunity, longevity, and self-protection against viruses.
Existing products made using outdated technologies (essential oils, alcoholic, glycerin, and water extracts, essences, elixirs, etc.) either show negligible antioxidant activity or act like antibiotics, damaging the microbiome. Prebiotics and probiotics address the problem non-systemically and ineffectively.
Business Development Stage:
– Product development and validation completed in the US market
– Sales started in the US in 2024
– Product portfolio consists of 300 products
– Own scientific and production base in the EU
– Technology patented
Growth Strategy:
Market leadership in microbiome product solutions in North America and Europe in the mid-price segment. Sales development through interaction with pharmaceutical doctors (more than 3,000 specialists) who will recommend the systemic microbiome support approach to patients by providing them with unique educational content.
